It was a busy third quarter for Quest Diagnostics (Lyndhurst, NJ). The company spent $230 million to acquire Focus Diagnostics and Enterix while working to wind down operations of Nichols Institute Diagnostics (NID; San Clemente, CA), its troubled test kit manufacturing subsidiary. Quest posted third-quarter revenue of $1.6 billion, up 16.3% from last year. The company attributed 9.4% of the revenue increase to LabOne, which it completed the purchase of on Nov. 1, 2005, while newly acquired Focus added 1% to revenues. So far this year, Quest’s revenues are up 17.1% to $4.7 billion, about 10% of which is due to the LabOne acquisition.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

November 2006 - Table of Contents

LIR November 2006 (full PDF issue)

United Healthcare Awards Exclusive 10-Year Contract to LabCorp

Self-Referral Crackdown: Pod Labs in CMS’s Crosshairs

Medicare Part B Premiums to Go Up 6% Next Year

Quest ’06 Revenues Up 17%, Driven by Esoteric Testing and LabOne

Lab Institute Highlights Medicare Reimbursement Squeeze, Need for Collaboration

Steady Growth Projected for Hospital Lab Sector

UnitedHealth CEO Resigns Over Stock Options Scandal

Canada’s Largest Lab Services Provider Sold for $1.2 Billion

Lab Stocks Up 11%; Quest Is Only Loser

Keys to Outreach Competition